Close Menu

Sell, Sell, Sell

Too many in the scientific community, particularly those who control the funding, regard the commercialization of science as something "dirty," says the University of Leeds' Deputy Vice-Chancellor John Fisher in New Scientist. They say "that inspiration alone should be the driving force behind scientific labor," but this is just a "myth," Fisher says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.